S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
NYSE:BBWI

Bath & Body Works (BBWI) Stock Forecast, Price & News

$33.11
-0.96 (-2.82%)
(As of 09/22/2023 ET)
Compare
Today's Range
$32.77
$34.55
50-Day Range
$34.07
$39.33
52-Week Range
$30.52
$49.55
Volume
3.11 million shs
Average Volume
3.49 million shs
Market Capitalization
$7.53 billion
P/E Ratio
10.79
Dividend Yield
2.42%
Price Target
$46.69

Bath & Body Works MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
41.0% Upside
$46.69 Price Target
Short Interest
Healthy
3.48% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.97
Upright™ Environmental Score
News Sentiment
1.24mentions of Bath & Body Works in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
18.39%
From $3.10 to $3.67 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Retail/Wholesale Sector

42nd out of 196 stocks

Womens' Clothing Stores Industry

2nd out of 5 stocks


BBWI stock logo

About Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.

BBWI Price History

BBWI Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Bath & Body Works (BBWI) Receives a Buy from Robert W. Baird
Goldman Sachs Remains a Buy on Bath & Body Works (BBWI)
Urban Outfitters sales rise in Q2 earnings beat
See More Headlines
Receive BBWI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bath & Body Works and its competitors with MarketBeat's FREE daily newsletter.

BBWI Company Calendar

Ex-Dividend for 9/1 Dividend
8/17/2023
Last Earnings
8/23/2023
Dividend Payable
9/01/2023
Today
9/22/2023
Next Earnings (Estimated)
11/15/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Womens' clothing stores
Sub-Industry
N/A
Employees
57,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$46.69
High Stock Price Forecast
$61.00
Low Stock Price Forecast
$37.00
Forecasted Upside/Downside
+40.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
14 Analysts

Profitability

Net Income
$800 million
Pretax Margin
12.54%

Debt

Sales & Book Value

Annual Sales
$7.56 billion
Cash Flow
$4.22 per share
Book Value
($9.47) per share

Miscellaneous

Free Float
226,949,000
Market Cap
$7.56 billion
Optionable
Not Optionable
Beta
1.74
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Ms. Gina R. Boswell (Age 60)
    CEO & Director
    Comp: $3.06M
  • Mr. Michael C. Wu (Age 56)
    Chief Legal Officer & Corp. Sec.
    Comp: $2.97M
  • Ms. Deon N. Riley (Age 55)
    Chief HR Officer
    Comp: $3.37M
  • Ms. Julie B. Rosen (Age 57)
    Pres of Retail
    Comp: $4.28M
  • Ms. Eva C. Boratto (Age 56)
    Chief Financial Officer
  • Mr. Thilina Gunasinghe
    Chief Digital & Technology Officer
  • Ms. Heather Hollander
    VP of Investor Relations
  • Mr. Bruce A. Soll (Age 65)
    Sr. VP & Counsel of Company Affairs
  • Mr. Brian K. Leinbach
    Exec. VP & CIO
  • Mr. Tom Mazurek (Age 56)
    Chief Supply Chain Officer













BBWI Stock - Frequently Asked Questions

Should I buy or sell Bath & Body Works stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bath & Body Works in the last year. There are currently 6 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" BBWI shares.
View BBWI analyst ratings
or view top-rated stocks.

What is Bath & Body Works' stock price forecast for 2023?

14 Wall Street research analysts have issued 1-year price targets for Bath & Body Works' stock. Their BBWI share price forecasts range from $37.00 to $61.00. On average, they anticipate the company's stock price to reach $46.69 in the next year. This suggests a possible upside of 40.4% from the stock's current price.
View analysts price targets for BBWI
or view top-rated stocks among Wall Street analysts.

How have BBWI shares performed in 2023?

Bath & Body Works' stock was trading at $42.14 at the beginning of 2023. Since then, BBWI stock has decreased by 21.1% and is now trading at $33.25.
View the best growth stocks for 2023 here
.

Are investors shorting Bath & Body Works?

Bath & Body Works saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 7,850,000 shares, an increase of 19.3% from the August 15th total of 6,580,000 shares. Based on an average daily volume of 3,860,000 shares, the short-interest ratio is presently 2.0 days. Approximately 3.5% of the company's shares are sold short.
View Bath & Body Works' Short Interest
.

When is Bath & Body Works' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 15th 2023.
View our BBWI earnings forecast
.

How were Bath & Body Works' earnings last quarter?

Bath & Body Works, Inc. (NYSE:BBWI) posted its quarterly earnings data on Wednesday, August, 23rd. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.07. The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Bath & Body Works had a net margin of 9.47% and a negative trailing twelve-month return on equity of 30.08%. Bath & Body Works's quarterly revenue was down 3.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.52 EPS.

How often does Bath & Body Works pay dividends? What is the dividend yield for Bath & Body Works?

Bath & Body Works declared a quarterly dividend on Friday, August 4th. Shareholders of record on Friday, August 18th will be paid a dividend of $0.20 per share on Friday, September 1st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.41%. The ex-dividend date of this dividend is Thursday, August 17th.
Read our dividend analysis for BBWI
.

Is Bath & Body Works a good dividend stock?

Bath & Body Works (NYSE:BBWI) pays an annual dividend of $0.80 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 26.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BBWI will have a dividend payout ratio of 21.80% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BBWI.

What guidance has Bath & Body Works issued on next quarter's earnings?

Bath & Body Works updated its FY24 earnings guidance on Wednesday, August, 23rd. The company provided earnings per share guidance of $2.80-3.10 for the period, compared to the consensus estimate of $3.04. The company issued revenue guidance of down 1.5-3.5% yr/yr to $7.30-7.45 billion, compared to the consensus revenue estimate of $7.48 billion.

What is Bath & Body Works' stock symbol?

Bath & Body Works trades on the New York Stock Exchange (NYSE) under the ticker symbol "BBWI."

Who are Bath & Body Works' major shareholders?

Bath & Body Works' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.15%), Third Point LLC (6.05%), State Street Corp (4.27%), Geode Capital Management LLC (2.17%), Champlain Investment Partners LLC (1.56%) and Northern Trust Corp (1.22%). Insiders that own company stock include Robert H Schottenstein, Thomas E Mazurek and Wendy C Arlin.
View institutional ownership trends
.

How do I buy shares of Bath & Body Works?

Shares of BBWI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bath & Body Works' stock price today?

One share of BBWI stock can currently be purchased for approximately $33.25.

How much money does Bath & Body Works make?

Bath & Body Works (NYSE:BBWI) has a market capitalization of $7.56 billion and generates $7.56 billion in revenue each year. The company earns $800 million in net income (profit) each year or $3.07 on an earnings per share basis.

How many employees does Bath & Body Works have?

The company employs 57,200 workers across the globe.

How can I contact Bath & Body Works?

Bath & Body Works' mailing address is PO Box 16000, Columbus, Ohio 43216-6000. The official website for the company is www.lb.com. The company can be reached via phone at (614) 415-7000, via email at investorrelations@lb.com, or via fax at 614-415-7080.

This page (NYSE:BBWI) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -